Evaluating shockwave and decongestive therapies for lipedema
Evaluation of Extracorporeal Shockwave Therapy (ESWT) and Complex Decongestive Therapy (CDT) Results in Patients With Lipoedema
This study is testing if shockwave therapy and special massage techniques can help people with lipedema feel less pain and improve their symptoms.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 33 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Giresun University Academic / other |
| Locations | 1 site (Giresun) |
| Trial ID | NCT06898125 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the effectiveness of Extracorporeal Shockwave Therapy and Complex Decongestive Therapy in patients diagnosed with lipedema. The methodology involves collecting data and analyzing it using various statistical tests to determine the therapies' impact on pain and other symptoms associated with lipedema. Participants will undergo these therapies, and their results will be compared before and after treatment to evaluate improvements. The study will utilize SPSS for data analysis, ensuring rigorous statistical evaluation of the outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are females aged 18 and older who have been diagnosed with type 1, 2, or 3 lipedema at stages 1, 2, or 3.
Not a fit: Patients with known rheumatic, endocrinological, neuromuscular, dermatological diseases, or those who have undergone surgery for lipedema may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide new therapeutic options for managing pain and symptoms in patients with lipedema.
How similar studies have performed: While there is limited data on the specific combination of therapies being tested, similar approaches have shown promise in managing symptoms of lipedema in other studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female * 18 years or older * Being diagnosed with lipedema according to Wold criteria * Having type 1, 2 and 3 lipedema * Having stage 1, 2 and 3 lipedema Exclusion Criteria: * Known rheumatic, endocrinological, neuromuscular, dermatological disease, kidney failure, liver failure and malignancy * Having undergone surgery for lipedema * Having poor circulation, open wound or infection in the lower extremities
Where this trial is running
Giresun
- Giresun University Training and Research Hospital — Giresun, Turkey (Recruiting)
Study contacts
- Study coordinator: Mihrinur Dilvin TÜRKÖZ
- Email: m.dilvinseker@gmail.com
- Phone: +905054696869
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.